These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28361832)

  • 1. Safety of yellow fever vaccine in Indian travellers: A prospective observational study.
    Tiwari P; Ahlawat R; Gupta G
    Indian J Med Res; 2016 Nov; 144(5):778-780. PubMed ID: 28361832
    [No Abstract]   [Full Text] [Related]  

  • 2. Yellow fever - prevention in travellers.
    Neilson AA; Mayer CA
    Aust Fam Physician; 2010 Aug; 39(8):570-3. PubMed ID: 20877751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yellow fever: epidemiology and prevention.
    Barnett ED
    Clin Infect Dis; 2007 Mar; 44(6):850-6. PubMed ID: 17304460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more.
    Miyaji KT; Luiz AM; Lara AN; do Socorro Souza Chaves T; Piorelli Rde O; Lopes MH; Sartori AM
    Hum Vaccin Immunother; 2013 Feb; 9(2):277-82. PubMed ID: 23291944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rarity of adverse effects after 17D yellow-fever vaccination.
    Marianneau P; Georges-Courbot M; Deubel V
    Lancet; 2001 Jul; 358(9276):84-5. PubMed ID: 11463403
    [No Abstract]   [Full Text] [Related]  

  • 6. How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?
    Thomas RE; Spragins W; Lorenzetti DL
    Vaccine; 2013 Dec; 31(52):6201-9. PubMed ID: 24436960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period.
    Tanizaki R; Ujiie M; Hori N; Kanagawa S; Kutsuna S; Takeshita N; Hayakawa K; Kato Y; Ohmagari N
    J Travel Med; 2016 Mar; 23(3):. PubMed ID: 27021495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinations for international travellers travelling from Greece.
    Pavli A; Spilioti A; Lymperi I; Katerelos P; Maltezou HC
    Travel Med Infect Dis; 2013; 11(4):225-30. PubMed ID: 23433917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellow Fever outbreaks in unvaccinated populations, Brazil, 2008-2009.
    Romano AP; Costa ZG; Ramos DG; Andrade MA; Jayme Vde S; Almeida MA; Vettorello KC; Mascheretti M; Flannery B
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2740. PubMed ID: 24625634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of vaccination against yellow fever of persons traveling to endemic areas].
    Dabrowska MM; Flisiak R
    Przegl Epidemiol; 2010; 64(2):319-22. PubMed ID: 20731245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Flavivirus infections: yellow fever, dengue fever and Japanese encephalitis].
    Buhl MR
    Ugeskr Laeger; 2005 Oct; 167(43):4076-80. PubMed ID: 16251091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First case of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) in Hong Kong.
    Leung WS; Chan MC; Chik SH; Tsang TY
    J Travel Med; 2016 Apr; 23(4):. PubMed ID: 27087559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viscerotropic disease following yellow fever vaccination in Peru.
    Whittembury A; Ramirez G; Hernández H; Ropero AM; Waterman S; Ticona M; Brinton M; Uchuya J; Gershman M; Toledo W; Staples E; Campos C; Martínez M; Chang GJ; Cabezas C; Lanciotti R; Zaki S; Montgomery JM; Monath T; Hayes E
    Vaccine; 2009 Oct; 27(43):5974-81. PubMed ID: 19679215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse event reports following yellow fever vaccination, 2007-13.
    Lindsey NP; Rabe IB; Miller ER; Fischer M; Staples JE
    J Travel Med; 2016 May; 23(5):. PubMed ID: 27378369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Travel and yellow fever vaccine.
    Arya SC
    J Travel Med; 2002; 9(6):334. PubMed ID: 12962592
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil.
    Martins Rde M; Pavão AL; de Oliveira PM; dos Santos PR; Carvalho SM; Mohrdieck R; Fernandes AR; Sato HK; de Figueiredo PM; von Doellinger Vdos R; Leal Mda L; Homma A; Maia Mde L
    Vaccine; 2014 Nov; 32(49):6676-82. PubMed ID: 24837504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yellow fever vaccine. WHO position paper.
    World Health Organization
    Wkly Epidemiol Rec; 2003 Oct; 78(40):349-59. PubMed ID: 14569711
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of yellow fever in travellers: an update.
    Reno E; Quan NG; Franco-Paredes C; Chastain DB; Chauhan L; Rodriguez-Morales AJ; Henao-Martínez AF
    Lancet Infect Dis; 2020 Jun; 20(6):e129-e137. PubMed ID: 32386609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events following yellow fever vaccination in immunocompromised persons.
    Lara AN; Miyaji KT; Ibrahim KY; Lopes MH; Sartori AMC
    Rev Inst Med Trop Sao Paulo; 2021; 63():e13. PubMed ID: 33656136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.